Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation

被引:13
|
作者
Gazourian, Lee [1 ]
Coronata, Anna Maria F. [1 ]
Rogers, Angela J. [1 ,2 ]
Weinhouse, Gerald L. [1 ]
Soiffer, Robert J. [3 ]
Antin, Joseph H. [3 ]
Ritz, Jerome [3 ]
Ho, Vincent T. [3 ]
Baron, Rebecca M. [1 ]
Washko, George R. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Computed tomography; Bone marrowtransplantation; Bronchiolitis obliterans syndrome; Airway disease; BONE-MARROW-TRANSPLANTATION; THIN-SECTION CT; RESOLUTION COMPUTED-TOMOGRAPHY; OBSTRUCTIVE LUNG-DISEASE; VERSUS-HOST-DISEASE; FLOW OBSTRUCTION; RISK-FACTORS; RECIPIENTS; DIMENSIONS; EMPHYSEMA;
D O I
10.1016/j.rmed.2012.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Bronchiolitis obliterans syndrome (BOS) is a late, non-infectious pulmonary complication following hematopoietic stem cell transplantation (HSCT). There is minimal data published on quantitative radiologic characterization of airway remodeling in these subjects. Objectives: To examine quantitative measurements of airway morphology and their correlation with lung function in a cohort of patients who underwent HSCT and developed BOS. Methods: All adult patients who underwent allogeneic HSCT at the Dana-Farber Cancer Institute/Brigham and Women's Hospital (n = 1854) between January 1st 2000 and June 30th 2010 were screened for the development of BOS. Clinically acquired high resolution CT (HRCT) scans of the chest were collected. For each subjects discrete measures of airway wall area were performed and the square root of wall area of a 10-mm luminal perimeter (Pi 10) was calculated. Measurements and main results: We identified 88 cases of BOS, and 37 of these patients had available HRCT. On CT scans obtained after BOS diagnosis, the Pi10 decreased (consistent with airway dilation) as compared with pre-BOS values (p < 0.001). After HSCT the Pi10 correlated with FEV1% predicted (r = 0.636, p < 0.0001), and RV/TLC% predicted (r = -0.736, p < 0.0001), even after adjusting for age, sex and total lung capacity (p < 0.0001 for both). Conclusions: On HRCT scan BOS is characterized by central airway dilation, the degree of which is correlated to decrements in lung function. This is opposite of what has been previously demonstrated in COPD and asthma that quantitative measure of proximal airway wall thickening directly correlate with pulmonary function. Our data suggests that the pathologic process affecting the central airways is different from the pathology observed in the distal airways. Further work is needed to determine if such change can be used as a sensitive and specific tool for the future diagnosis and staging of BOS. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 50 条
  • [1] Airway Dilation in Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Gazourian, Lee
    Coronata, Anna Maria F.
    Rogers, Angela J.
    Weinhouse, Gerald L.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ritz, Jerome
    Ho, Vincent T.
    Baron, Rebecca M.
    Washko, George R.
    BLOOD, 2012, 120 (21)
  • [2] Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Williams, Kirsten M.
    Chien, Jason W.
    Gladwin, Mark T.
    Pavletic, Steven Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (03): : 306 - 314
  • [3] Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    S Watanabe
    Y Waseda
    H Kimura
    H Takato
    K Ohata
    Y Kondo
    K Kasahara
    S Nakao
    Bone Marrow Transplantation, 2015, 50 : 1250 - 1252
  • [4] Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    Watanabe, S.
    Waseda, Y.
    Kimura, H.
    Takato, H.
    Ohata, K.
    Kondo, Y.
    Kasahara, K.
    Nakao, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 (09) : 1250 - 1252
  • [5] Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
    Kim, Yu Ri
    Haam, Seok Jin
    Park, Yoon Ghil
    Lim, Beom Jin
    Park, Yoo Mi
    Paik, Hyo Chae
    YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 1054 - 1057
  • [6] Ruxolitinib for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
    Kulagin, Egor A.
    Volkova, Alisa G.
    Dotsenko, Anna A.
    Yanbukhtina, Valeria R.
    Rabik, Julia D.
    Smirnova, Anna G.
    Golubovskaya, Irina K.
    Trofimov, Vasiliy I.
    Moiseev, Ivan S.
    BLOOD, 2021, 138
  • [7] Nintedanib in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
    Tang, Wenjiao
    Yu, Ting
    Dong, Tian
    Liu, Ting
    Ji, Jie
    CHEST, 2020, 158 (03) : E89 - E91
  • [8] Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation: Unresolved Questions
    Holm, Martin
    Riise, Gerdt C.
    Brinch, Lorentz
    Bjortuft, Oystein
    Iversen, Martin
    Simonsen, Svein
    Floisand, Yngvar
    TRANSPLANTATION, 2013, 96 (04) : E21 - E22
  • [9] Imatinib Mesylate (Gleevec®) And Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Rivaud, E.
    Tcherakian, C.
    Metivier, A. -C.
    Neveu, H.
    Vernant, J. P.
    Couderc, L. J.
    Dhedin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [10] Retrospective Analysis of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
    Chen, Yingyao
    Xu, Jun
    Fan, Zhiping
    Xu, Na
    Huang, Fen
    Shi, Pengcheng
    Liu, Qifa
    Sun, Jing
    BLOOD, 2021, 138